Back to News
Market Impact: 0.6

Michelob Ultra overtakes Modelo Especial as best-selling beer in the U.S.

STZBUD
Consumer Demand & RetailCompany FundamentalsTax & TariffsTrade Policy & Supply ChainCorporate Guidance & OutlookElections & Domestic PoliticsCorporate Earnings
Michelob Ultra overtakes Modelo Especial as best-selling beer in the U.S.

Michelob Ultra has surpassed Modelo Especial as the best-selling beer in the U.S. retail and on-premise channels, signaling a significant market shift and a reversal of fortunes for Anheuser-Busch following Bud Light's previous decline. This development coincides with Constellation Brands facing headwinds, including tariffs on Mexican imports and aluminum, and weakened demand from its historically strong Hispanic consumer base, prompting a revised fiscal year sales forecast of a 2-4% decline. The diverging performance is reflected in year-to-date stock movements, with AB InBev up 16% and Constellation Brands down 39%.

Analysis

A significant shift has occurred in the U.S. beer market, with Anheuser-Busch's (BUD) Michelob Ultra displacing Constellation Brands' (STZ) Modelo Especial as the top-selling beer. This development marks a notable recovery for Anheuser-Busch, whose market leadership was previously lost following brand challenges with Bud Light. The success of Michelob Ultra is comprehensive, spanning both retail channels and on-premise sales. Conversely, Constellation Brands is navigating a confluence of adverse conditions, including tariffs on aluminum and Mexican imports, and weakening demand from its historically strong Hispanic consumer base. These pressures have forced a material downward revision of its fiscal year guidance, with the company now forecasting a net beer sales decline of 2% to 4%, a stark reversal from its prior expectation of flat to 3% growth. The market has priced in these diverging fortunes, reflected in the year-to-date stock performance where BUD has appreciated over 16% while STZ has declined 39%.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo